{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:18:41Z","timestamp":1783484321052,"version":"3.55.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R03EB026189"],"award-info":[{"award-number":["R03EB026189"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ftirma Kurumu","doi-asserted-by":"publisher","award":["2219\/2008"],"award-info":[{"award-number":["2219\/2008"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2017XYBP2R"],"award-info":[{"award-number":["2017XYBP2R"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008097","name":"Edward N. and Della L. Thome Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.bioorg.2020.104204","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T11:32:58Z","timestamp":1598441578000},"page":"104204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Pyridinium derivatives of 3-aminobenzenesulfonamide are nanomolar-potent inhibitors of tumor-expressed carbonic anhydrase isozymes CA IX and CA XII"],"prefix":"10.1016","volume":"103","author":[{"given":"Suleyman","family":"Akocak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zlen","family":"G\u00fczel-Akdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Kishore Kumar Sanku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samson S.","family":"Russom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan I.","family":"Iorga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Ilies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bioorg.2020.104204_b0005","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of Cancer: The Next Generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bioorg.2020.104204_b0010","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc704","article-title":"Hypoxia\u2013a key regulatory factor in tumour growth","volume":"2","author":"Harris","year":"2002","journal-title":"Nat. Rev. Can."},{"issue":"4 Pt 1","key":"10.1016\/j.bioorg.2020.104204_b0015","first-page":"L818","article-title":"Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung","volume":"275","author":"Yu","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.bioorg.2020.104204_b0020","first-page":"176","article-title":"Hydroxylation of HIF-1: oxygen sensing at the molecular level","volume":"19","author":"Semenza","year":"2004","journal-title":"Physiology (Bethesda)"},{"issue":"4","key":"10.1016\/j.bioorg.2020.104204_b0025","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.tips.2012.01.005","article-title":"Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy","volume":"33","author":"Semenza","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"issue":"6","key":"10.1016\/j.bioorg.2020.104204_b0030","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1634\/theoncologist.12-6-690","article-title":"Review: implications of in vitro research on the effect of radiotherapy and chemotherapy under hypoxic conditions","volume":"12","author":"Wouters","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.bioorg.2020.104204_b0035","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.bioorg.2020.104204_b0040","first-page":"2877","article-title":"Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment","volume":"9","author":"Pastorek","year":"1994","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2020.104204_b0045","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1201\/9780203475300.ch9","article-title":"Cancer-related carbonic anhydrase isozymes and their inhibition","author":"Pastorekova","year":"2004","journal-title":"Carbonic Anhydrase"},{"issue":"38","key":"10.1016\/j.bioorg.2020.104204_b0050","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1073\/pnas.0908301106","article-title":"Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX","volume":"106","author":"Alterio","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"24","key":"10.1016\/j.bioorg.2020.104204_b0055","first-page":"7075","article-title":"Hypoxia-inducible expression of tumor-associated carbonic anhydrases","volume":"60","author":"Wykoff","year":"2000","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.bioorg.2020.104204_b0060","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4161\/cc.3.2.618","article-title":"Hypoxia inducible carbonic anhydrase IX, marker of tumour hypoxia, survival pathway and therapy target","volume":"3","author":"Potter","year":"2004","journal-title":"Cell Cycle"},{"issue":"5","key":"10.1016\/j.bioorg.2020.104204_b0065","first-page":"1005","article-title":"Carbonic anhydrase IX, a marker of hypoxia: correlation with clinical outcome in transitional cell carcinoma of the bladder","volume":"11","author":"Hussain","year":"2004","journal-title":"Oncol Rep"},{"key":"10.1016\/j.bioorg.2020.104204_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-8-1","article-title":"Carbonic anhydrase IX in oligodendroglial brain tumors","volume":"8","author":"Jarvela","year":"2008","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.bioorg.2020.104204_b0075","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s004180000181","article-title":"Expression of transmembrane carbonic anhydrase isoenzymes IX and XII in normal human pancreas and pancreatic tumours","volume":"114","author":"Kivela","year":"2000","journal-title":"Histochem Cell Biol"},{"issue":"1","key":"10.1016\/j.bioorg.2020.104204_b0080","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/sj.bjc.6603530","article-title":"Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer","volume":"96","author":"Hussain","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bioorg.2020.104204_b0085","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2014.08.002","article-title":"Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use","volume":"31","author":"Pastorek","year":"2015","journal-title":"Semin Cancer Biol"},{"issue":"15","key":"10.1016\/j.bioorg.2020.104204_b0090","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.2174\/092986710790979999","article-title":"Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII","volume":"17","author":"Guler","year":"2010","journal-title":"Curr Med Chem"},{"issue":"6","key":"10.1016\/j.bioorg.2020.104204_b0095","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1002\/pmic.200300689","article-title":"Modulation of gene expression by hypoxia in human umbilical cord vein endothelial cells: A transcriptomic and proteomic study","volume":"4","author":"Scheurer","year":"2004","journal-title":"Proteomics"},{"issue":"10","key":"10.1016\/j.bioorg.2020.104204_b0100","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"10.1016\/j.bioorg.2020.104204_b0105","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1053\/gast.1997.v112.pm9024293","article-title":"Carbonic anhydrase IX, MN\/CA IX: analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts","volume":"112","author":"Pastorekova","year":"1997","journal-title":"Gastroenterology"},{"issue":"13","key":"10.1016\/j.bioorg.2020.104204_b0110","doi-asserted-by":"crossref","first-page":"7608","DOI":"10.1073\/pnas.95.13.7608","article-title":"Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers","volume":"95","author":"Tureci","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"10.1016\/j.bioorg.2020.104204_b0115","doi-asserted-by":"crossref","first-page":"9545","DOI":"10.1073\/pnas.161301298","article-title":"Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells","volume":"98","author":"Whittington","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"26","key":"10.1016\/j.bioorg.2020.104204_b0120","doi-asserted-by":"crossref","first-page":"14212","DOI":"10.1073\/pnas.97.26.14212","article-title":"Purification and kinetic analysis of recombinant CA XII, a membrane carbonic anhydrase overexpressed in certain cancers","volume":"97","author":"Ulmasov","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.bioorg.2020.104204_b0125","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/13543776.2019.1629419","article-title":"Carbonic anhydrases as disease markers","volume":"29","author":"Zamanova","year":"2019","journal-title":"Expert Opin Ther Pat"},{"issue":"17","key":"10.1016\/j.bioorg.2020.104204_b0130","doi-asserted-by":"crossref","first-page":"6160","DOI":"10.1158\/0008-5472.CAN-03-2224","article-title":"Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion","volume":"64","author":"Robertson","year":"2004","journal-title":"Cancer Res"},{"issue":"29","key":"10.1016\/j.bioorg.2020.104204_b0135","doi-asserted-by":"crossref","first-page":"20473","DOI":"10.1074\/jbc.M801330200","article-title":"Tumor-associated carbonic anhydrase 9 spatially coordinates intracellular pH in three-dimensional multicellular growths","volume":"283","author":"Swietach","year":"2008","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.bioorg.2020.104204_b0140","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1158\/0008-5472.CAN-08-2470","article-title":"Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH","volume":"69","author":"Chiche","year":"2009","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.bioorg.2020.104204_b0145","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/jcp.22400","article-title":"pH control mechanisms of tumor survival and growth","volume":"226","author":"Parks","year":"2011","journal-title":"J Cell Physiol"},{"issue":"12","key":"10.1016\/j.bioorg.2020.104204_b0150","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/13543784.2018.1548608","article-title":"Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors","volume":"27","author":"Supuran","year":"2018","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.bioorg.2020.104204_b0155","series-title":"Targeted Nanosystems for Therapeutic Applications: New Concepts, Dynamic Properties, Efficiency, and Toxicity","first-page":"223","article-title":"Drug Delivery to Hypoxic Tumors Targeting Carbonic Anhydrase IX","author":"Shabana","year":"2019"},{"issue":"8","key":"10.1016\/j.bioorg.2020.104204_b0160","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem Rev"},{"issue":"14","key":"10.1016\/j.bioorg.2020.104204_b0165","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1042\/BCJ20160115","article-title":"Structure and function of carbonic anhydrases","volume":"473","author":"Supuran","year":"2016","journal-title":"Biochem J"},{"issue":"5","key":"10.1016\/j.bioorg.2020.104204_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.37358\/RC.20.5.8107","article-title":"A Simple Yet Multifaceted Enzyme","volume":"71","author":"Supuran","year":"2020","journal-title":"Rev Chim"},{"issue":"1","key":"10.1016\/j.bioorg.2020.104204_b0175","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1080\/14756366.2019.1664501","article-title":"Activation of \u03b1-, \u03b2-, \u03b3- \u03b4-, \u03b6- and \u03b7- class of carbonic anhydrases with amines and amino acids: a review","volume":"34","author":"Akocak","year":"2019","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bioorg.2020.104204_b0180","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bioorg.2018.10.005","article-title":"Design, synthesis and biological evaluation of novel ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as potent carbonic anhydrase IX inhibitors","volume":"82","author":"Lolak","year":"2019","journal-title":"Bioorg Chem"},{"issue":"5","key":"10.1016\/j.bioorg.2020.104204_b0185","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1073\/pnas.040554897","article-title":"Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro","volume":"97","author":"Parkkila","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.bioorg.2020.104204_b0190","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1021\/cr050262p","article-title":"Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding","volume":"108","author":"Krishnamurthy","year":"2008","journal-title":"Chem Rev"},{"issue":"1","key":"10.1016\/j.bioorg.2020.104204_b0195","doi-asserted-by":"crossref","first-page":"84","DOI":"10.18632\/oncotarget.422","article-title":"Recent developments in targeting carbonic anhydrase IX for cancer therapeutics","volume":"3","author":"McDonald","year":"2012","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.bioorg.2020.104204_b0200","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1021\/jm021123s","article-title":"Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogenosulfanilamide and halogenophenylaminobenzolamide derivatives","volume":"46","author":"Ilies","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.bioorg.2020.104204_b0205","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/978-94-007-7359-2_15","article-title":"Carbonic anhydrase inhibitors drug design","volume":"75","author":"McKenna","year":"2014","journal-title":"Subcell Biochem"},{"key":"10.1016\/j.bioorg.2020.104204_b0210","series-title":"Targeting carbonic anhydrases","first-page":"3","article-title":"Next generation primary sulfonamide carbonic anhydrase inhibitors","author":"Akocak","year":"2014"},{"issue":"11","key":"10.1016\/j.bioorg.2020.104204_b0215","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.4155\/fmc.15.71","article-title":"Carbonic anhydrase IX inhibitors in cancer therapy: an update","volume":"7","author":"Supuran","year":"2015","journal-title":"Future Med Chem"},{"issue":"6","key":"10.1016\/j.bioorg.2020.104204_b0220","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1517\/17460441.2015.1038235","article-title":"Designing carbonic anhydrase inhibitors for the treatment of breast cancer","volume":"10","author":"Supuran","year":"2015","journal-title":"Expert Opin Drug Discov"},{"issue":"10","key":"10.1016\/j.bioorg.2020.104204_b0225","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1021\/acs.jmedchem.6b00492","article-title":"PEGylated Bis-Sulfonamide Carbonic Anhydrase Inhibitors Can Efficiently Control the Growth of Several Carbonic Anhydrase IX-Expressing Carcinomas","volume":"59","author":"Akocak","year":"2016","journal-title":"Journal of Medicinal Chemistry"},{"issue":"10","key":"10.1016\/j.bioorg.2020.104204_b0230","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/13543776.2018.1508453","article-title":"Carbonic anhydrase inhibitors as antitumor\/antimetastatic agents: a patent review (2008\u20132018)","volume":"28","author":"Nocentini","year":"2018","journal-title":"Expert Opin Ther Pat"},{"issue":"21","key":"10.1016\/j.bioorg.2020.104204_b0235","doi-asserted-by":"crossref","first-page":"17792","DOI":"10.1021\/acsami.8b05607","article-title":"pH-Sensitive Multiligand Gold Nanoplatform Targeting Carbonic Anhydrase IX Enhances the Delivery of Doxorubicin to Hypoxic Tumor Spheroids and Overcomes the Hypoxia-Induced Chemoresistance","volume":"10","author":"Shabana","year":"2018","journal-title":"ACS Appl Mater Interfaces"},{"issue":"15","key":"10.1016\/j.bioorg.2020.104204_b0240","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.2174\/0929867325666180622120625","article-title":"State of the Art on Carbonic Anhydrase Modulators for Biomedical Purposes","volume":"26","author":"Bozdag","year":"2019","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bioorg.2020.104204_b0245","doi-asserted-by":"crossref","unstructured":"Ilies, M.A. and J.-Y. Winum, Chapter 16 - Carbonic anhydrase inhibitors for the treatment of tumors: therapeutic, immunologic, and diagnostic tools targeting isoforms IX and XII, in Carbonic Anhydrases, C.T. Supuran and A. Nocentini, Editors. 2019, Academic Press. p. 331-365.","DOI":"10.1016\/B978-0-12-816476-1.00016-2"},{"issue":"12","key":"10.1016\/j.bioorg.2020.104204_b0250","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1016\/j.bmc.2017.03.063","article-title":"Synthesis and biological evaluation of novel aromatic and heterocyclic bis-sulfonamide Schiff bases as carbonic anhydrase I, II, VII and IX inhibitors","volume":"25","author":"Akocak","year":"2017","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bioorg.2020.104204_b0255","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-94-007-7359-2_17","article-title":"Glaucoma and the applications of carbonic anhydrase inhibitors","volume":"75","author":"Scozzafava","year":"2014","journal-title":"Subcell Biochem"},{"issue":"8","key":"10.1016\/j.bioorg.2020.104204_b0260","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.bmc.2019.03.001","article-title":"Discovery of new ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as carbonic anhydrase I, II, IX and XII inhibitors","volume":"27","author":"Lolak","year":"2019","journal-title":"Bioorg Med Chem"},{"issue":"10","key":"10.1016\/j.bioorg.2020.104204_b0265","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1016\/j.bmc.2004.03.008","article-title":"Carbonic anhydrase inhibitors: aromatic and heterocyclic sulfonamides incorporating adamantyl moieties with strong anticonvulsant activity","volume":"12","author":"Ilies","year":"2004","journal-title":"Bioorg Med Chem"},{"issue":"15","key":"10.1016\/j.bioorg.2020.104204_b0270","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1016\/j.bmcl.2010.06.082","article-title":"Carbonic anhydrase inhibitors. The X-ray crystal structure of human isoform II in adduct with an adamantyl analogue of acetazolamide resides in a less utilized binding pocket than most hydrophobic inhibitors","volume":"20","author":"Avvaru","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"issue":"2","key":"10.1016\/j.bioorg.2020.104204_b0275","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/14756360109162361","article-title":"Carbonic anhydrase inhibitors: synthesis and inhibition against isozymes I, II and IV of topically acting antiglaucoma sulfonamides incorporating cis-5-norbornene-endo-3-carboxy-2-carboxamido moieties","volume":"16","author":"Casini","year":"2001","journal-title":"J Enzyme Inhib"},{"issue":"24","key":"10.1016\/j.bioorg.2020.104204_b0280","doi-asserted-by":"crossref","first-page":"6204","DOI":"10.1016\/j.bmcl.2006.09.022","article-title":"Carbonic anhydrase inhibitors: X-ray crystallographic studies for the binding of 5-amino-1,3,4-thiadiazole-2-sulfonamide and 5-(4-amino-3-chloro-5-fluorophenylsulfonamido)-1,3,4-thiadiazole-2-sulfonamide to human isoform II","volume":"16","author":"Menchise","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"issue":"8","key":"10.1016\/j.bioorg.2020.104204_b0285","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.bmc.2013.02.022","article-title":"Structural effect of phenyl ring compared to thiadiazole based adamantyl-sulfonamides on carbonic anhydrase inhibition","volume":"21","author":"Biswas","year":"2013","journal-title":"Bioorganic & medicinal chemistry"},{"issue":"18","key":"10.1016\/j.bioorg.2020.104204_b0290","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1021\/jm050333c","article-title":"Carbonic anhydrase inhibitors: stacking with Phe131 determines active site binding region of inhibitors as exemplified by the X-ray crystal structure of a membrane-impermeant antitumor sulfonamide complexed with isozyme II","volume":"48","author":"Menchise","year":"2005","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.bioorg.2020.104204_b0295","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0022-3565(25)32717-5","article-title":"Dextran-bound inhibitors of carbonic anhydrase","volume":"218","author":"Tinker","year":"1981","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.bioorg.2020.104204_b0300","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0022-3565(24)36415-8","article-title":"Renal and cerebrospinal fluid formation pharmacology of a high molecular weight carbonic anhydrase inhibitor","volume":"280","author":"Maren","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.bioorg.2020.104204_b0305","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bmcl.2003.09.063","article-title":"Carbonic anhydrase inhibitors: N-(p-sulfamoylphenyl)-alpha-D-glycopyranosylamines as topically acting antiglaucoma agents in hypertensive rabbits","volume":"14","author":"Winum","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"issue":"22","key":"10.1016\/j.bioorg.2020.104204_b0310","doi-asserted-by":"crossref","first-page":"6539","DOI":"10.1021\/jm060967z","article-title":"A novel class of carbonic anhydrase inhibitors: glycoconjugate benzene sulfonamides prepared by \u201cclick-tailing\u201d","volume":"49","author":"Wilkinson","year":"2006","journal-title":"J Med Chem"},{"issue":"18","key":"10.1016\/j.bioorg.2020.104204_b0315","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1016\/j.bmcl.2007.07.019","article-title":"Carbonic anhydrase inhibitors: Selective inhibition of the extracellular, tumor-associated isoforms IX and XII over isozymes I and II with glycosyl-thioureido-sulfonamides","volume":"17","author":"Smaine","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"issue":"7","key":"10.1016\/j.bioorg.2020.104204_b0320","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1021\/jm901888x","article-title":"Sulfonamide linked neoglycoconjugates\u2013a new class of inhibitors for cancer-associated carbonic anhydrases","volume":"53","author":"Lopez","year":"2010","journal-title":"Journal of medicinal chemistry"},{"issue":"19","key":"10.1016\/j.bioorg.2020.104204_b0325","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.1021\/jm200892s","article-title":"Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors","volume":"54","author":"Morris","year":"2011","journal-title":"Journal of medicinal chemistry"},{"issue":"7","key":"10.1016\/j.bioorg.2020.104204_b0330","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1016\/j.bmc.2012.01.052","article-title":"Design and synthesis of thiourea compounds that inhibit transmembrane anchored carbonic anhydrases","volume":"20","author":"Moeker","year":"2012","journal-title":"Bioorganic & medicinal chemistry"},{"issue":"7","key":"10.1016\/j.bioorg.2020.104204_b0335","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/jps.2600810726","article-title":"Carbonic anhydrase inhibitors. V: Pyrylium salts in the synthesis of isozyme-specific inhibitors","volume":"81","author":"Supuran","year":"1992","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.bioorg.2020.104204_b0340","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0223-5234(98)80042-1","article-title":"Carbonic anhydrase inhibitors - Part 29: Interaction of isozymes I, II and IV with benzolamide-like derivatives","volume":"33","author":"Supuran","year":"1998","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"7\u20138","key":"10.1016\/j.bioorg.2020.104204_b0345","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0223-5234(98)80017-2","article-title":"Carbonic anhydrase inhibitors - Part 53 - Synthesis of substituted-pyridinium derivatives of aromatic sulfonamides: The first non-polymeric membrane-impermeable inhibitors with selectivity for isozyme IV","volume":"33","author":"Supuran","year":"1998","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"2","key":"10.1016\/j.bioorg.2020.104204_b0350","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1021\/jm990479+","article-title":"Carbonic anhydrase inhibitors: synthesis of membrane-impermeant low molecular weight sulfonamides possessing in vivo selectivity for the membrane-bound versus cytosolic isozymes","volume":"43","author":"Scozzafava","year":"2000","journal-title":"J Med Chem"},{"issue":"4","key":"10.1016\/j.bioorg.2020.104204_b0355","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/14756360009040695","volume":"15","author":"Supuran","year":"2000","journal-title":"J Enzyme Inhib"},{"issue":"4","key":"10.1016\/j.bioorg.2020.104204_b0360","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.bmcl.2003.12.029","article-title":"Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX","volume":"14","author":"Pastorekova","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"issue":"9","key":"10.1016\/j.bioorg.2020.104204_b0365","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1021\/jm031079w","article-title":"Carbonic anhydrase inhibitors. Design of selective, membrane-impermeant inhibitors targeting the human tumor-associated isozyme IX","volume":"47","author":"Casey","year":"2004","journal-title":"J Med Chem"},{"issue":"6","key":"10.1016\/j.bioorg.2020.104204_b0370","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3109\/14756366.2015.1113407","article-title":"Carbonic anhydrase inhibition for the management of cerebral ischemia: in vivo evaluation of sulfonamide and coumarin inhibitors","volume":"31","author":"Di Cesare Mannelli","year":"2016","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"9","key":"10.1016\/j.bioorg.2020.104204_b0375","doi-asserted-by":"crossref","first-page":"7431","DOI":"10.1007\/s12035-017-0854-2","article-title":"Crystal Structure of Carbonic Anhydrase II in Complex with an Activating Ligand: Implications in Neuronal Function","volume":"55","author":"Bhatt","year":"2018","journal-title":"Mol Neurobiol"},{"issue":"45","key":"10.1016\/j.bioorg.2020.104204_b0380","doi-asserted-by":"crossref","first-page":"5980","DOI":"10.1039\/C4CC02346C","article-title":"Ethylene bis-imidazoles are highly potent and selective activators for isozymes VA and VII of carbonic anhydrase, with a potential nootropic effect","volume":"50","author":"Draghici","year":"2014","journal-title":"Chem Commun (Camb)"},{"issue":"2","key":"10.1016\/j.bioorg.2020.104204_b0385","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1021\/jm011031n","article-title":"Carbonic Anhydrase Activators: Design of High Affinity Isozymes I, II, and IV Activators, Incorporating Tri-\/Tetrasubstituted-pyridinium-azole Moieties","volume":"45","author":"Ilies","year":"2002","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.bioorg.2020.104204_b0390","unstructured":"Balaban, T.S. and A.T. Balaban, Pyrylium Salts, in Science of Synthesis. Houben-Weyl Methods of Molecular Transformations, T.E. J., Editor. 2003, G. Thieme Verlag: Stuttgart. p. 11-200."},{"key":"10.1016\/j.bioorg.2020.104204_b0395","doi-asserted-by":"crossref","DOI":"10.1021\/jm4009532","article-title":"Hypoxia-Targeting Carbonic Anhydrase IX Inhibitors by a New Series of Nitroimidazole-Sulfonamides\/Sulfamides\/Sulfamates","author":"Rami","year":"2013","journal-title":"Journal of medicinal chemistry"},{"issue":"8","key":"10.1016\/j.bioorg.2020.104204_b0400","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.bioorg.2020.104204_b0405","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/prot.10465","article-title":"Improved protein-ligand docking using GOLD","volume":"52","author":"Verdonk","year":"2003","journal-title":"Proteins"},{"issue":"14","key":"10.1016\/j.bioorg.2020.104204_b0410","doi-asserted-by":"crossref","first-page":"6328","DOI":"10.1021\/acs.jmedchem.8b00770","article-title":"Discovery of 4-Hydroxy-3-(3-(phenylureido)benzenesulfonamides as SLC-0111 Analogues for the Treatment of Hypoxic Tumors Overexpressing Carbonic Anhydrase IX","volume":"61","author":"Bozdag","year":"2018","journal-title":"J Med Chem"},{"issue":"Pt 10","key":"10.1016\/j.bioorg.2020.104204_b0415","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1107\/S2059798319010027","article-title":"Structural comparison of protiated, H\/D-exchanged and deuterated human carbonic anhydrase IX","volume":"75","author":"Koruza","year":"2019","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"10.1016\/j.bioorg.2020.104204_b0420","doi-asserted-by":"crossref","unstructured":"Kazokait\u0117, J., R. Niemans, V. Dudutien\u0117, H.M. Becker, J. Leit\u0101ns, A. Zubrien\u0117, L. Baranauskien\u0117, G. Gondi, R. Zeidler, J. Matulien\u0117, K. T\u0101rs, A. Yaromina, P. Lambin, L.J. Dubois, and D. Matulis, Novel fluorinated carbonic anhydrase IX inhibitors reduce hypoxia-induced acidification and clonogenic survival of cancer cells. Oncotarget; Vol 9, No 42, 2018.","DOI":"10.18632\/oncotarget.25508"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820315017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820315017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:52:17Z","timestamp":1777463537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206820315017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":84,"alternative-id":["S0045206820315017"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.104204","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyridinium derivatives of 3-aminobenzenesulfonamide are nanomolar-potent inhibitors of tumor-expressed carbonic anhydrase isozymes CA IX and CA XII","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.104204","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104204"}}